Development of a unique crosslinked glycosaminoglycan for soft tissue repair: Treatment of interstitial cystitis/bladder pain syndrome.
Chemical modification of naturally derived glycosaminoglycans (GAGs) expands their potential utility for applications in soft tissue repair and regenerative medicine. Here we report the preparation of a novel crosslinked chondroitin sulfate (~200 to 2000 kilodaltons) that is both soluble in aqueous...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0317790 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832540213409218560 |
|---|---|
| author | Richard W Heidebrecht Thomas H Jozefiak Harrison C Shain Eugene M Skrabut Debra Saunders Nataliya Smith Rheal A Towner Robert Hurst |
| author_facet | Richard W Heidebrecht Thomas H Jozefiak Harrison C Shain Eugene M Skrabut Debra Saunders Nataliya Smith Rheal A Towner Robert Hurst |
| author_sort | Richard W Heidebrecht |
| collection | DOAJ |
| description | Chemical modification of naturally derived glycosaminoglycans (GAGs) expands their potential utility for applications in soft tissue repair and regenerative medicine. Here we report the preparation of a novel crosslinked chondroitin sulfate (~200 to 2000 kilodaltons) that is both soluble in aqueous solution and microfilterable. We refer to these materials as "SuperGAGs." One can further conjugate these materials with diverse capture agents to further modify polymer properties and add new capabilities. A representative material (GLX-100) demonstrated durable restoration of bladder impermeability in a gold standard animal model of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). Histologic examination of the animal bladders treated with a GLX-100 SuperGAG conjugated to biotin as a reporter demonstrated that the residence time of GLX-100 is superior to chondroitin sulfate (a product that is currently used for clinical treatment of patients with IC/BPS). As expected, this novel crosslinked GAG biopolymer was restricted to the luminal surface of the bladder wall. In this communication we describe a simple and versatile synthesis of a crosslinked glycosaminoglycan (GAG) biopolymer for soft tissue repair. Chondroitin sulfate (~12 kD) was crosslinked to form a water soluble and microfilterable polymer with approximately 200 to 2000 kD molecular weight. The synthesis presented here allows for control of molecular weight while avoiding formation of an extended block gel. Moreover, the procedure enables further chemical modification of the SuperGAG through the selection of a capture agent. A set of agents have been used, demonstrating the preparation of a family of SuperGAGs with diverse capabilities. We can optimize polymer properties, adjust adherence to various tissues, add reporters, and engage the biochemistry of surrounding tissues with peptides and other bioactives. |
| format | Article |
| id | doaj-art-d41565663dc2480db79d0f94a3698a3b |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-d41565663dc2480db79d0f94a3698a3b2025-02-05T05:32:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201e031779010.1371/journal.pone.0317790Development of a unique crosslinked glycosaminoglycan for soft tissue repair: Treatment of interstitial cystitis/bladder pain syndrome.Richard W HeidebrechtThomas H JozefiakHarrison C ShainEugene M SkrabutDebra SaundersNataliya SmithRheal A TownerRobert HurstChemical modification of naturally derived glycosaminoglycans (GAGs) expands their potential utility for applications in soft tissue repair and regenerative medicine. Here we report the preparation of a novel crosslinked chondroitin sulfate (~200 to 2000 kilodaltons) that is both soluble in aqueous solution and microfilterable. We refer to these materials as "SuperGAGs." One can further conjugate these materials with diverse capture agents to further modify polymer properties and add new capabilities. A representative material (GLX-100) demonstrated durable restoration of bladder impermeability in a gold standard animal model of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). Histologic examination of the animal bladders treated with a GLX-100 SuperGAG conjugated to biotin as a reporter demonstrated that the residence time of GLX-100 is superior to chondroitin sulfate (a product that is currently used for clinical treatment of patients with IC/BPS). As expected, this novel crosslinked GAG biopolymer was restricted to the luminal surface of the bladder wall. In this communication we describe a simple and versatile synthesis of a crosslinked glycosaminoglycan (GAG) biopolymer for soft tissue repair. Chondroitin sulfate (~12 kD) was crosslinked to form a water soluble and microfilterable polymer with approximately 200 to 2000 kD molecular weight. The synthesis presented here allows for control of molecular weight while avoiding formation of an extended block gel. Moreover, the procedure enables further chemical modification of the SuperGAG through the selection of a capture agent. A set of agents have been used, demonstrating the preparation of a family of SuperGAGs with diverse capabilities. We can optimize polymer properties, adjust adherence to various tissues, add reporters, and engage the biochemistry of surrounding tissues with peptides and other bioactives.https://doi.org/10.1371/journal.pone.0317790 |
| spellingShingle | Richard W Heidebrecht Thomas H Jozefiak Harrison C Shain Eugene M Skrabut Debra Saunders Nataliya Smith Rheal A Towner Robert Hurst Development of a unique crosslinked glycosaminoglycan for soft tissue repair: Treatment of interstitial cystitis/bladder pain syndrome. PLoS ONE |
| title | Development of a unique crosslinked glycosaminoglycan for soft tissue repair: Treatment of interstitial cystitis/bladder pain syndrome. |
| title_full | Development of a unique crosslinked glycosaminoglycan for soft tissue repair: Treatment of interstitial cystitis/bladder pain syndrome. |
| title_fullStr | Development of a unique crosslinked glycosaminoglycan for soft tissue repair: Treatment of interstitial cystitis/bladder pain syndrome. |
| title_full_unstemmed | Development of a unique crosslinked glycosaminoglycan for soft tissue repair: Treatment of interstitial cystitis/bladder pain syndrome. |
| title_short | Development of a unique crosslinked glycosaminoglycan for soft tissue repair: Treatment of interstitial cystitis/bladder pain syndrome. |
| title_sort | development of a unique crosslinked glycosaminoglycan for soft tissue repair treatment of interstitial cystitis bladder pain syndrome |
| url | https://doi.org/10.1371/journal.pone.0317790 |
| work_keys_str_mv | AT richardwheidebrecht developmentofauniquecrosslinkedglycosaminoglycanforsofttissuerepairtreatmentofinterstitialcystitisbladderpainsyndrome AT thomashjozefiak developmentofauniquecrosslinkedglycosaminoglycanforsofttissuerepairtreatmentofinterstitialcystitisbladderpainsyndrome AT harrisoncshain developmentofauniquecrosslinkedglycosaminoglycanforsofttissuerepairtreatmentofinterstitialcystitisbladderpainsyndrome AT eugenemskrabut developmentofauniquecrosslinkedglycosaminoglycanforsofttissuerepairtreatmentofinterstitialcystitisbladderpainsyndrome AT debrasaunders developmentofauniquecrosslinkedglycosaminoglycanforsofttissuerepairtreatmentofinterstitialcystitisbladderpainsyndrome AT nataliyasmith developmentofauniquecrosslinkedglycosaminoglycanforsofttissuerepairtreatmentofinterstitialcystitisbladderpainsyndrome AT rhealatowner developmentofauniquecrosslinkedglycosaminoglycanforsofttissuerepairtreatmentofinterstitialcystitisbladderpainsyndrome AT roberthurst developmentofauniquecrosslinkedglycosaminoglycanforsofttissuerepairtreatmentofinterstitialcystitisbladderpainsyndrome |